http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2009013683-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_148bb3787e93a2b26b6706919d621953 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-015 |
| filingDate | 2008-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4a0bee61a504395df086350021c580f |
| publicationDate | 2010-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2009013683-A |
| titleOfInvention | MATERIALS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS. |
| abstract | The present invention relates to materials and methods for the treatment and prevention of pathologies associated with oxidative stress or a compromised reducing medium, including inflammatory bowel diseases such as Crohn's disease. and ulcerative colitis; Another aspect of the present invention relates to compositions formulated for administration as an enema; in one embodiment, a composition suitable for administration as an enema comprises an effective amount of 5-ASA and a steroid such as budesonide or hydrocortisone; The present invention also relates to compositions formulated for oral administration; in one embodiment, a composition comprises alpha-lipidic acid, and / or N-acetyl-L-Cysteine (NAC), and / or L-glutamine; the alpha-lipidic acid may be racic alpha-lipidic acid, R-lipidic acid, or lipidic R-dihydro acid; The methods of the invention include the administration of the compounds or compositions of the invention; in one embodiment, the compounds or compositions of the invention are rectally instilled in a patient; in another embodiment, the compounds or compositions are orally administered; The present invention also relates to methods for the detection of, evaluation of developmental risks, and / or diagnosis of the conditions associated with oxidative stress, such as ulcerative colitis and other disorders. of inflammatory bowel. |
| priorityDate | 2007-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.